The American Medical Association says obesity should be classified as a disease. CNBC's Bertha Coombs reports AMA's Patrice Harris says the hope is for doctors to be more proactive in treating obese patients.» Read More
LONDON, June 10- One of the world's longest running drug development sagas may draw to a close this month as French firm Sanofi hopes for a European green light for its new multiple sclerosis medicine Lemtrada.
AstraZeneca is to buy U.S. respiratory drug specialist Pearl Therapeutics for up to $1.15 billion, as Britain's second biggest drugmaker steps up a drive to rebuild its product pipeline via deal-making.
LONDON, June 10- AstraZeneca is to buy U.S. respiratory drug specialist Pearl Therapeutics for up to $1.15 billion as Britain's second biggest drugmaker steps up a drive to rebuild its product pipeline via deal-making.
Allergy season has been getting longer every year for 15 years, with Dr. Michael Foggs of American College of Allergy, Asthma and Immunology; and Stephen Brozak, WBB Securities, discusses the big money in the allergy business.
With its cheap multiple and serious upside potential, Cramer thinks this stock could give your portfolio a kick.
CNBC's John Harwood provides perspective on President Obama's address on health care, invasion of privacy concerns, and his meeting later today with China's President Xi.
President Obama answers questions about privacy concerns surrounding the NSA's collection of telephone records and monitoring of Internet activity. "Congress is continually briefed" on how these activities are conducted, Obama says.
President Obama explains the "two main things Americans need to know" about the new legislation on health care. The President outlines how competition will provide an incentive to keep health care costs down, and cover millions of people who currently don't have insurance coverage.
CNBC's John Harwood provides a preview of the President's address on the benefits of the Affordable Care Act. He also addresses the NSA phone records issue.
CNBC's John Harwood presents a preview of President Obama's statement on the Affordable Care Act, and likely comments on this morning's better-than-expected jobs number, as pressure mounts for him to address NSA privacy concerns ahead of his meeting later today with China's President Xi.
Royalty Pharma raised its hostile bid for Irish drug firm Elan to a potential $8 billion on Friday, coming back for the third time after just 7.5 percent of shareholders accepted the last offer.
A new study released Friday discovered that an average of 15 percent of flexible endoscopes used to examine GI tracts and colons at five hospitals were dirty.
DUBLIN, June 7- Royalty Pharma raised its hostile bid for Irish drug firm Elan to a potential $8 billion on Friday, after just 7.5 percent of the target company's shareholders accepted its previous offer.
Joseph Jimenez, CEO of Novartis, says the pharmaceutical company is investing heavily to introduce new drugs in China as the spotlight shifts from infectious to chronic disease.
Forcing hospital workers to be vaccinated for the flu as a condition of employment is not a prescription for losing employees, according to a new study.
John Noseworthy, Mayo Clinic president and CEO, discusses what his company is doing to create more jobs, the best opportunities internationally for growth and Obamacare.
Escalating costs represent one of the predictable outcomes of health reform, and many employers will turn to alternative solutions, says Keith Lemer, president of WellNet Healthcare.
Reynolds American is launching its Vuse electronic cigarettes in Colorado, with an eye toward quick national expansion. Company executives say the product will alter the landscape.
Steve Wiggins, Essex Woodlands, provides his take on companies that are best positioned to profit from ObamaCare.
Time to begin picking through the rubble, looking for stocks that have already been crushed, Cramer said.